搜索结果

Search Results for " ruxolitinib "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T1829	Ruxolitinib 芦可替尼,INCB018424,鲁索替尼,(R)-Ruxolitinib	Apoptosis; Mitophagy; Tyrosine Kinases; JAK; Autophagy	Angiogenesis; Apoptosis; Autophagy; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
	Ruxolitinib (INCB018424) 是一种 JAK1/2 抑制剂 (IC50=3.3/2.8 nM)，具有有效性和选择性。Ruxolitinib 具有抗肿瘤活性，可以诱导细胞自噬和凋亡。
T6156	Ruxolitinib (S enantiomer) S-Ruxolitinib,环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯,Ruxolitinib S enantiomer,INCB018424,INCB18424	Tyrosine Kinases; JAK	Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
	Ruxolitinib S enantiomer (INCB18424) 是 Ruxolitinib 的 S 型对映体，是一种JAK 抑制剂。
T3043	Ruxolitinib phosphate INC424,INCB018424,INC 424 phosphate,Ruxolitinib (INCB-18424) phosphate,INCB018424 phosphate,磷酸鲁索利替尼	Mitophagy; JAK; Autophagy	Angiogenesis; Autophagy; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells
	Ruxolitinib phosphate (INCB018424) 是一种 JAK1/2抑制剂，IC50分别为3.3 nM/2.8 nM，对 JAK1/2 的选择性是 JAK3 的 130 倍以上。
T61988	Ruxolitinib sulfate
	Ruxolitinib sulfate (INCB018424 sulfate) 是一种有效的JAK1/2抑制剂。Ruxolitinib sulfate 抑制JAK1/2的IC50为 3.3 nM/2.8 nM，高于 JAK3 130 倍。
T2476	INCB032304 4-(1H-吡唑-4-基)-7-((2-(三甲基硅烷基)乙氧基)-甲基)-7H-吡咯并[2,3-D]嘧啶,4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)-methyl)-7H-pyrrolo[2,3-d]pyrimidine	Others	Others
	INCB032304是一种重要的医药中间体。可用于制备janus 激酶抑制剂Ruxolitinib phosphate（I008849），也可于制备Barretinib。
T74994	SJ988497
	SJ988497是一种PROTACJAK2降解剂，有效地抑制CRLF2重排(CRLF2r)细胞增殖并降解CRBN新底物GSPT1。该化合物由Ruxolitinib衍生物、连接子以及CRBN配体Pomalidomide构成，可作为急性淋巴细胞白血病(ALL)研究用途。
T38158	StA-IFN-1
	StA-IFN-1 is an inhibitor of the interferon (IFN) induction pathway with an IC50 value of 4.1 μM in a GFP reporter assay for IFN induction similar to TPCA-1 , which specifically inhibits the IKKβ component of the IFN induction pathway. It does not show inhibitory activity in a GFP reporter assay for IFN signaling in which ruxolitinib , which is specific for the IFN signaling component JAK1, is active. StA-IFN-1 reduces the levels of IFN-β, but not ISG MxA, mRNA, suggesting that it is selective f...